534 related articles for article (PubMed ID: 33181246)
21. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR.
Abadie B; Ali AH; Martyn T; Higgins A; Krishnaswamy A; Reed G; Puri R; Yun J; Cremer P; Hanna M; Tang WHW; Kapadia S; Jaber W
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3910-3916. PubMed ID: 37606857
[TBL] [Abstract][Full Text] [Related]
23. Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week.
Ternacle J; Krapf L; Mohty D; Magne J; Nguyen A; Galat A; Gallet R; Teiger E; Côté N; Clavel MA; Tournoux F; Pibarot P; Damy T
J Am Coll Cardiol; 2019 Nov; 74(21):2638-2651. PubMed ID: 31753206
[TBL] [Abstract][Full Text] [Related]
24. Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
Fatima K; Uddin QS; Tharwani ZH; Kashif MAB; Javaid SS; Kumar P; Zia MT; Javed M; Butt MS; Asim Z
Int J Cardiol; 2024 May; 402():131854. PubMed ID: 38367883
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis.
Ho JS; Kor Q; Kong WK; Lim YC; Chan MY; Syn NL; Ngiam JN; Chew NW; Yeo TC; Chai P; Poh KK; Wong RC; Lin W; Sia CH
Hellenic J Cardiol; 2022; 64():67-76. PubMed ID: 34856378
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Initiation of a Transcatheter Aortic Valve Replacement Program in the Treatment of Severe Aortic Stenosis.
Ad N; Holmes SD; Shuman DJ; Rongione AJ; Massimiano PS; Speir AM; Pritchard G; Yazdani S; Raybuck BD
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):353-360. PubMed ID: 28043443
[TBL] [Abstract][Full Text] [Related]
27. Elevated high-sensitivity troponin T levels at 1-year follow-up are associated with increased long-term mortality after TAVR.
Seoudy H; Lambers M; Winkler V; Dudlik L; Freitag-Wolf S; Frank J; Kuhn C; Rangrez AY; Puehler T; Lutter G; Bramlage P; Frey N; Frank D
Clin Res Cardiol; 2021 Mar; 110(3):421-428. PubMed ID: 33098469
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
[TBL] [Abstract][Full Text] [Related]
30. Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.
Fukui M; Gupta A; Abdelkarim I; Sharbaugh MS; Althouse AD; Elzomor H; Mulukutla S; Lee JS; Schindler JT; Gleason TG; Cavalcante JL
JAMA Cardiol; 2019 Mar; 4(3):215-222. PubMed ID: 30725109
[TBL] [Abstract][Full Text] [Related]
31. In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
Gallone G; Landra F; D'Ascenzo F; Conrotto F; Casoni R; Bruno F; Omedè P; Alunni G; Andreis A; Vairo A; Giorgi M; Fava A; De Ferrari GM
BMC Cardiovasc Disord; 2020 Jun; 20(1):261. PubMed ID: 32487051
[TBL] [Abstract][Full Text] [Related]
32. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
[TBL] [Abstract][Full Text] [Related]
34. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
35. Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients With Cardiac Amyloidosis.
Gama F; Rosmini S; Bandula S; Patel KP; Massa P; Tobon-Gomez C; Ecke K; Stroud T; Condron M; Thornton GD; Bennett JB; Wechelakar A; Gillmore JD; Whelan C; Lachmann H; Taylor SA; Pugliese F; Fontana M; Moon JC; Hawkins PN; Treibel TA
JACC Cardiovasc Imaging; 2022 Dec; 15(12):2082-2094. PubMed ID: 36274040
[TBL] [Abstract][Full Text] [Related]
36. Cardiac Amyloidosis in Patients Undergoing TAVR: Why We Need to Think About It.
Cappelli F; Perfetto F; Martone R; Di Mario C
Cardiovasc Revasc Med; 2021 Jan; 22():109-114. PubMed ID: 32571759
[TBL] [Abstract][Full Text] [Related]
37. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
[TBL] [Abstract][Full Text] [Related]
38. Transfemoral aortic valve replacement in a nonagenarian with aortic stenosis and cardiac amyloidosis: case report.
Akras D; Bullinger K; Kondapaneni M; Siraj A; Akhrass R; Aneja A
J Cardiothorac Surg; 2022 Mar; 17(1):32. PubMed ID: 35260184
[TBL] [Abstract][Full Text] [Related]
39. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F
JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
